tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Market Movers
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

Abivax to Host Webcast on Ulcerative Colitis Treatments and Phase 3 Trial Insights
Company AnnouncementsAbivax to Host Webcast on Ulcerative Colitis Treatments and Phase 3 Trial Insights
2d ago
Abivax management to meet with Piper Sandler
PremiumThe Fly
Abivax management to meet with Piper Sandler
18d ago
ABVX
Abivax Releases 2025 Financial Communication Schedule
PremiumCompany Announcements
Abivax Releases 2025 Financial Communication Schedule
26d ago
Abivax Discloses Share Capital and Voting Rights Information
PremiumCompany Announcements
Abivax Discloses Share Capital and Voting Rights Information
27d ago
Abivax Presents Key Findings on Obefazimod at ECCO 2025
PremiumCompany Announcements
Abivax Presents Key Findings on Obefazimod at ECCO 2025
1M ago
Abivax Achieves Significant Progress in Phase 3 Ulcerative Colitis Trial
PremiumCompany AnnouncementsAbivax Achieves Significant Progress in Phase 3 Ulcerative Colitis Trial
1M ago
Abivax Announces Board Change as Key Director Resigns
Premium
Company Announcements
Abivax Announces Board Change as Key Director Resigns
2M ago
Abivax initiated with an Outperform at JMP Securities
Premium
The Fly
Abivax initiated with an Outperform at JMP Securities
3M ago
ABVX
Abivax SA Ends Liquidity Contract, Reports Cash Balance
PremiumCompany Announcements
Abivax SA Ends Liquidity Contract, Reports Cash Balance
4M ago
Abivax data support potential of obefazimod as UC treatment option
PremiumThe Fly
Abivax data support potential of obefazimod as UC treatment option
5M ago
ABVX
Abivax Expands Trial for Potential Crohn’s Disease Treatment
PremiumCompany Announcements
Abivax Expands Trial for Potential Crohn’s Disease Treatment
5M ago
Abivax’s Drug Shows Long-Term Efficacy in UC
PremiumCompany Announcements
Abivax’s Drug Shows Long-Term Efficacy in UC
5M ago
Abivax announces initial results from obefazimod combination mouse study
PremiumThe FlyAbivax announces initial results from obefazimod combination mouse study
5M ago
ABVX
Abivax Reports Share Capital and Voting Rights
Premium
Company Announcements
Abivax Reports Share Capital and Voting Rights
5M ago
Abivax management to meet virtually with Piper Sandler
Premium
The Fly
Abivax management to meet virtually with Piper Sandler
5M ago
ABVX
Abivax Reports Share Capital and Voting Rights
PremiumCompany Announcements
Abivax Reports Share Capital and Voting Rights
6M ago
Abivax SA’s Ulcerative Colitis Drug On Track for 2025
PremiumCompany Announcements
Abivax SA’s Ulcerative Colitis Drug On Track for 2025
7M ago
Alphabet upgraded, Arm downgraded: Wall Street’s top analyst calls
PremiumThe Fly
Alphabet upgraded, Arm downgraded: Wall Street’s top analyst calls
7M ago
GD
ARM
Abivax initiated with a Buy at Laidlaw
PremiumThe Fly
Abivax initiated with a Buy at Laidlaw
7M ago
ABVX
Abivax Progresses on Ulcerative Colitis Phase 3 Trial
PremiumCompany AnnouncementsAbivax Progresses on Ulcerative Colitis Phase 3 Trial
7M ago
Abivax Announces Share Capital and Voting Rights
Premium
Company Announcements
Abivax Announces Share Capital and Voting Rights
8M ago
Abivax Reports Share Capital and Voting Rights
Premium
Company Announcements
Abivax Reports Share Capital and Voting Rights
9M ago

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >